Skip to main content

Table 3 Neuropsychological tests values at baseline

From: A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

Test Placeboa Interferon beta 1aa Pvalue
ADAS-Cogb 19.81 ± 6.14 18.34 ± 7.85 0.34
MMSEc 22.93 ± 1.78 23.45 ± 2.13 0.41
ADAS-NonCogd 6.06 ± 5.0 4.36 ± 4.12 0.30
PSMSe 6.4 ± 0.91 6.42 ± 1.01 0.98
GDSf 10.66 ± 6.53 10.10 ± 6.12 0.79
Global DSg 2.86 ± 0.74 3.0 ± 0.47 0.50
IADLh 6.2 ± 1.56 6.1 ± 1.44 0.68
  1. aValues are expressed as means ± SD. bADAS-cog, Alzheimer’s Disease Assessment Scale-cognitive subscale; cMMSE, Mini Mental State Examination; dADAS-Non-Cog, Alzheimer’s Disease Assessment Scale-Non-Cognitive Section; ePSMS, Physical Self-Maintenance Scale; fGDS, Geriatric Depression Scale; Global, gGlobal Deterioration Scale (DS) for Assessment of Primary Degenerative Dementia; hIADL, Instrumental Activities of Daily Living Scale.